Could AI avert a future coronavirus pandemic?

Could AI prevent future pandemics by developing an armoury of drugs that work against all coronaviruses?

AI drug discovery firm Exscientia gets $60M cash injection

UK artificial intelligence specialist Exscientia has topped up its coffers with a $60 million Series C funding round that will be used to advance projects into clinical trials.

AI specialist Exscientia signs drug discovery tie-up with Ba...

AI specialist Exscientia forms rare disease JV with RallyBio

GSK adds to COPD pipeline as Exscientia deal bears fruit

AI drug research firm Exscientia has delivered the first candidate molecule to its partner GlaxoSmithKline following an R&D tie-up signed in 2017.

AI drug R&D firm Exscientia expands into Japan

AI drug R&D firm Exscientia has announced it has expanded into Japan, after clinching a major research deal with Celgene.